Ezra Rolls Out World’s First 30-Minute Full-Body MRI To Detect Cancer Early
Ezra, the healthcare AI startup transforming early cancer detection through full-body MRI screening, announced today that its newest proprietary Artificial Intelligence, Ezra Flash, has received 510(k) clearance by the U.S. Food and Drug Administration (FDA).
Ezra Flash enhances the quality of MR images, making it possible for Ezra to decrease the time needed to complete a high-quality scan, thereby reducing MRI costs. The company will use this technology to launch the world’s first 30-minute full-body MRI scan.
“Over 1.9 million people are expected to be diagnosed with cancer in the U.S. in 2023 according to the American Cancer Society. Our mission at Ezra is to detect cancer early for everyone in the world, and I’m really excited about this new AI enabling us to make our scan more affordable,” said Emi Gal, founder and CEO of Ezra. “By boosting quality while reducing scan time, we’re decreasing our cost for a full body MRI by 30%, and we’re passing these cost savings to our customers.”